Biogen shares soar as FDA reviewers support Alzheimer’s drug

DUBLIN: Biogen’s experimental Alzheimer’s disease therapy appears effective despite conflicting clinical-trial results, according to a…
DUBLIN: Biogen’s experimental Alzheimer’s disease therapy appears effective despite conflicting clinical-trial results, according to a…